Phibro Animal Health | 税前利润

金融业

USD

USD 1.41B

现金及等价物

USD 55.49M

USD 207.39M

USD 862.19M

USD 282.37M

USD 474.17M

股息收益率

2.13

USD 26M

USD 30.48M

1.92K

EPS每股收益

USD 0.08

股本和储备

USD 332.36M

USD 101.87M

债务利息支出

USD 8.76M

USD 0.08

USD 603.6M

USD 2.09B

USD 3.19M

USD 332.36M

USD 25.53M

普通股股本

USD 4K

48.92

USD 4.84M

USD 309.26M

销售和管理费用

USD 76.34M

USD 517.35M

贸易债权人

USD 133.3M

应收帐款人

USD 160.78M

	税前利润	更改		日
Align Technology	USD 176.6M		81.86M	2025-12
ANI Pharmaceuticals	USD 49.52M		39M	2025-09
Assertio Holdings	USD -2.88M		648K	2024-09
Aurora Cannabis	CAD 46.98M		66.36M	2025-09
Bristol-Myers Squibb	USD 3.11B		1.34B	2025-09
Canopy Growth	CAD -1.42M		39.82M	2025-09
Corcept Therapeutics	USD 15.24M		16.45M	2025-09
Eli Lilly	USD 7.23B		456M	2025-09
Henry Schein	USD 137M		16M	2025-09
Idexx Laboratories	USD 306.98M		37.79M	2025-12
Knight Therapeutics	CAD -1.92M		13.69M	2025-09
Merck	USD 6.74B		22M	2025-09
Nektar Therapeutics	USD -37.05M		15.27M	2024-09
Pacira	USD -1.93M		10.63M	2025-06
Phibro Animal Health	USD 4.84M		4.78M	2024-12
Prestige Brands	USD 69.13M		7.35M	2025-09
Supernus Pharmaceuticals	USD -57.95M		74.62M	2025-09
Zoetis	USD 887M		15M	2025-09

Phibro Animal Health 税前利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.